Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Seizures × Vigabatrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2 Seizures 1

Interventions

Cannabidiol 3 perampanel 2 enzalutamide 1 Vigabatrin 1 Standard of Care 1 Levetiracetam 1 Everolimus 1 Cholecalciferol 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡